Akademska digitalna zbirka SLovenije - logo
E-viri
Recenzirano Odprti dostop
  • Vaccination rates and adher...
    Laurenz, Maren; von Eiff, Christof; Borchert, Kathrin; Jacob, Christian; Seidel, Karolin; Schley, Katharina

    Vaccine, 06/2021, Letnik: 39, Številka: 24
    Journal Article

    •STIKO changed PCV recommendation (mature infants) from 3+1 to 2+1 scheme in 2015.•Almost 10% of children remained unvaccinated in 2013 and 2016.•The rate of the booster dose increased slightly (birth cohort 2013 vs 2016).•Nearly 25% of the infants born in 2016 did not receive a booster dose.•The PCV booster dose was administered on time in less than half of infants in 2016. In August 2015, the German Standing Committee on Vaccination (STIKO) changed the pneumococcal conjugate vaccination (PCV) schedule for mature infants from a 3+1 scheme to a 2+1 scheme. It was expected that a reduction of doses would be associated with a higher acceptance of the vaccination. Aim of this study was to assess vaccination rates and adherence for PCV after the change of recommendation based on real-world data. A retrospective claims data analysis using the InGef Research Database was conducted. The study population consisted of all mature infants born in 2013 (last birth cohort completely under 3+1 recommendation) or 2016 (first birth cohort completely under 2+1 recommendation) with an individual follow-up of 24 months. Hexavalent combination vaccination (HEXA) with a consistent 3+1 recommendation was analyzed as reference. After follow-up of 24 months, 90.9% (91.2%) of the 2016 (2013) cohort received at least one dose of PCV. At the same age, 67.7% of the 2013 cohort received a booster dose according to the 3+1 schedule and 75.6% of the 2016 cohort received a booster dose presumably either according to the 2+1 (71.7%) or 3+1 (3.9%) schedule. Of those receiving the booster dose, only 46.3% (2016) and 45.1% (2013) received the booster dose on time as recommended. The HEXA vaccination rate increased from 88.9% (2013) to 91.6% (2016) with a full series completion in 69.1% (2013) vs 72.9% (2016). The proportion of infants receiving the booster vaccination on time rose to 50.0% in 2016 (47.8% in 2013). Although the rate for the PCV booster dose slightly increased, nearly a quarter of the infants born in 2016 did not receive a booster dose at all. Furthermore, vaccinations were still frequently delayed, and the rate of unvaccinated infants remained constant.